CA2644116A1 - Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents - Google Patents
Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents Download PDFInfo
- Publication number
- CA2644116A1 CA2644116A1 CA002644116A CA2644116A CA2644116A1 CA 2644116 A1 CA2644116 A1 CA 2644116A1 CA 002644116 A CA002644116 A CA 002644116A CA 2644116 A CA2644116 A CA 2644116A CA 2644116 A1 CA2644116 A1 CA 2644116A1
- Authority
- CA
- Canada
- Prior art keywords
- neural stem
- stem cell
- days
- cell proliferating
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78350006P | 2006-03-17 | 2006-03-17 | |
| US60/783,500 | 2006-03-17 | ||
| US78913206P | 2006-04-05 | 2006-04-05 | |
| US60/789,132 | 2006-04-05 | ||
| US86266906P | 2006-10-24 | 2006-10-24 | |
| US60/862,669 | 2006-10-24 | ||
| PCT/CA2007/000427 WO2007106987A1 (en) | 2006-03-17 | 2007-03-16 | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2644116A1 true CA2644116A1 (en) | 2007-09-27 |
Family
ID=38521972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002644116A Abandoned CA2644116A1 (en) | 2006-03-17 | 2007-03-16 | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| CA002643502A Abandoned CA2643502A1 (en) | 2006-03-17 | 2007-03-16 | Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002643502A Abandoned CA2643502A1 (en) | 2006-03-17 | 2007-03-16 | Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8143220B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2004212A4 (cg-RX-API-DMAC7.html) |
| JP (4) | JP2009530234A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20080103108A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2007229300B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2644116A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL193856A0 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2007106986A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1423509A2 (en) * | 2001-08-30 | 2004-06-02 | Stem Cell Therapeutics Inc. | Differentiation of neural stem cells and therapeutic use thereof |
| ES2392282T3 (es) | 2004-02-13 | 2012-12-07 | Stem Cell Therapeutics Corp. | Uso de la hormona luteinizante (LH) y de la gonadotropina coriónica (hCG) para la proliferación de células precursoras neurales y la neurogénesis |
| KR20080074108A (ko) | 2005-09-27 | 2008-08-12 | 스템 셀 테라퓨틱스 코포레이션 | 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식 |
| WO2007106986A1 (en) | 2006-03-17 | 2007-09-27 | Stem Cell Therapeutics Corp. | Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
| CN101517883B (zh) * | 2006-09-25 | 2012-07-04 | 国立大学法人东京农工大学 | 超声波操作装置和微细管内检查系统 |
| JP2011505335A (ja) * | 2007-09-11 | 2011-02-24 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | 治療剤としてのTRP−6−トリプトレリンおよびD−Leu6−ロイプロリドの使用 |
| US8198083B1 (en) | 2007-10-31 | 2012-06-12 | William Gunter Loudon | Organotypic slices of the central nervous system |
| MX2011009967A (es) * | 2009-03-26 | 2012-01-25 | Ford Henry Health System | Composiciones y metodo para mejorar el resultado neurologico despues de daño neural y enfermedad neurodegenerativa. |
| US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
| US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
| WO2012156968A2 (en) * | 2011-05-19 | 2012-11-22 | Ariel - University Research And Development Company, Ltd. | Use of mesenchymal stem cells for the improvement of affective and cognitive function |
| WO2013112002A1 (ko) * | 2012-01-27 | 2013-08-01 | 의료법인 성광의료재단 | 뇌 손상 증세의 경감 또는 완화에 대한 바이오마커 |
| BR112015008753A2 (pt) | 2012-10-18 | 2017-07-04 | Neuralight Hd Llc | tratamento de depressão e ptsd |
| US11253549B2 (en) | 2014-05-23 | 2022-02-22 | JangoBio, LLC | Methods to rebalance the hypothalamic-pituitary-gonadal axis |
| US11439668B2 (en) | 2014-05-23 | 2022-09-13 | JangoBio, LLC | Methods to differentiate stem cells into hormone-producing cells |
| WO2017179225A1 (ja) * | 2016-04-13 | 2017-10-19 | 味の素株式会社 | 加齢に伴う身体機能低下もしくは身体機能障害、または加齢に伴う精神機能低下もしくは精神機能障害の抑制または改善用組成物 |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4840896A (en) * | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
| NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| KR850004274A (ko) | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
| US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| US4902680A (en) | 1984-10-29 | 1990-02-20 | Chaovanee Aroonsakul | Treating central nervous system diseases |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4801575A (en) | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| WO1990004788A1 (en) | 1988-10-28 | 1990-05-03 | Genentech, Inc. | Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| WO1990005185A1 (fr) | 1988-11-07 | 1990-05-17 | L'universite De L'etat A Liege | Hormone de croissance humaine modifiee |
| US5128242A (en) | 1989-06-19 | 1992-07-07 | The Administrators Of The Tulane Educational Fund | Hypothalamic polypeptides with adenylate cyclase stimulating activity |
| US5198542A (en) | 1989-06-20 | 1993-03-30 | Takeda Chemical Industries, Inc. | Dna encoding a pitvitary adenylate cyclase activating protein and use thereof |
| US5977307A (en) | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| US6329508B1 (en) | 1989-09-07 | 2001-12-11 | Alkermes, Inc. | Transferrin receptor reactive chimeric antibodies |
| US5527527A (en) | 1989-09-07 | 1996-06-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
| US5268164A (en) | 1990-04-23 | 1993-12-07 | Alkermes, Inc. | Increasing blood-brain barrier permeability with permeabilizer peptides |
| EP0467279A3 (en) | 1990-07-18 | 1992-08-05 | Takeda Chemical Industries, Ltd. | Polypeptides having c-amp producing activity |
| US5521069A (en) | 1990-08-10 | 1996-05-28 | Takeda Chemical Industries, Ltd. | Genomic DNA exons having exons encoding human pituitary adenylate cyclase activity peptide with 38 amino acids residues(PACAP38) and a promoter thereof |
| US5189179A (en) | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
| US5231178A (en) | 1991-01-16 | 1993-07-27 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
| US5723115A (en) | 1991-05-02 | 1998-03-03 | W. Alton Jones Cell Science Center, Inc. | Inhibition of adipose tissue development and obesity |
| ATE196548T1 (de) | 1991-05-10 | 2000-10-15 | Genentech Inc | Auswählen von agonisten und antagonisten von liganden |
| US6429186B1 (en) | 1991-05-10 | 2002-08-06 | Genentech, Inc. | Ligand antagonists for treatment of breast cancer |
| US6294346B1 (en) | 1991-07-08 | 2001-09-25 | Neurospheres Holdings, Ltd. | Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents |
| US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| FI935929L (fi) | 1991-07-08 | 1994-02-02 | Neurospheres Ltd | Ny vaext regulerande faktor i stamcellen som foermaor foeroeka in vitro |
| US5750376A (en) | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| US5980885A (en) | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | Growth factor-induced proliferation of neural precursor cells in vivo |
| AU2489992A (en) | 1991-08-16 | 1993-03-16 | Chiron Corporation | Muteins of epidermal growth factor exhibiting enhanced binding at low ph |
| US5623050A (en) | 1991-08-22 | 1997-04-22 | Takeda Chemical Industries, Ltd. | Stable polypeptides having c-AMP production enhancing activity and the use thereof |
| US5253648A (en) | 1991-10-11 | 1993-10-19 | Spacelabs Medical, Inc. | Method and apparatus for excluding artifacts from automatic blood pressure measurements |
| EP0639981A4 (en) | 1992-05-08 | 1995-06-28 | Univ Jefferson | ANALOGS OF THE IGF FACTOR (01/18/94). |
| US5614184A (en) | 1992-07-28 | 1997-03-25 | New England Deaconess Hospital | Recombinant human erythropoietin mutants and therapeutic methods employing them |
| ATE221117T1 (de) | 1992-10-16 | 2002-08-15 | Neurospheres Holdings Ltd | Remyelination unter verwendung von neuronalen stammzellen |
| ATE483795T1 (de) | 1992-10-28 | 2010-10-15 | Neurospheres Holdings Ltd | Biologische faktoren und neuronale stammzellen |
| US5877169A (en) | 1993-11-05 | 1999-03-02 | University Of Florida Research Foundation, Inc. | Methods of treatment of ischemic damage |
| DE69431993T2 (de) | 1993-11-09 | 2003-11-27 | Neurospheres Holding Ltd., Calgary | In situ modifikation und manipulation von stammzellen des zentralen nervensystems |
| US5773569A (en) | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
| US6399316B1 (en) | 1994-02-25 | 2002-06-04 | Takeda Chemical Industries, Ltd. | PACAP receptor protein, method for preparing said protein, and use thereof |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| US6239105B1 (en) | 1994-03-31 | 2001-05-29 | Barbara A. Brewitt | Homeopathic preparations of purified growth hormone |
| WO1995029690A1 (en) | 1994-04-29 | 1995-11-09 | The Trustees Of The University Of Pennsylvania | Biologically active peptides and methods of identifying the same |
| US5840576A (en) | 1994-07-20 | 1998-11-24 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
| US5885574A (en) | 1994-07-26 | 1999-03-23 | Amgen Inc. | Antibodies which activate an erythropoietin receptor |
| US5547143A (en) * | 1994-08-24 | 1996-08-20 | Alliedsignal Inc. | Seat belt retractor with integrated load limiter |
| US6680295B1 (en) | 1994-09-22 | 2004-01-20 | The Administrators Of The Tulane Educational Fund | Method and pharmaceutical composition for prevention and treatment of brain damage |
| JPH10505863A (ja) | 1994-09-22 | 1998-06-09 | ジ・アドミニストレーターズ・オブ・ザ・チューレン・エデュケイショナル・ファンド | 脳障害の予防および治療のための方法および医薬組成物 |
| FI971956L (fi) | 1994-11-14 | 1997-07-04 | Neurospheres Holdings Ltd | Hermosolujen lisääntymisen säännöstely |
| US6015555A (en) | 1995-05-19 | 2000-01-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| AU6163196A (en) | 1995-06-07 | 1996-12-30 | Smithkline Beecham Corporation | Method for obtaining receptor agonist antibodies |
| US5547993A (en) | 1995-10-24 | 1996-08-20 | Mitsubishi Chemical Corporation | Therapeutic agent for glaucoma |
| WO1997016169A1 (en) | 1995-11-01 | 1997-05-09 | Chiron Corporation | Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
| US6346390B1 (en) | 1996-03-08 | 2002-02-12 | Receptron, Inc. | Receptor derived peptides involved in modulation of response to ligand binding |
| US6017533A (en) | 1996-04-25 | 2000-01-25 | Shiseido Company, Ltd. | Peptides having specific affinity to pituitary adenylate cyclase activating polypeptide type 1 receptors |
| US5753506A (en) | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
| AU3492497A (en) | 1996-06-21 | 1998-01-07 | Arris Pharmaceutical Corporation | Bivalent molecules that form an activating complex with an erythropoietin receptor |
| IT1284876B1 (it) | 1996-08-07 | 1998-05-22 | Applied Research Systems | Hcg come inibitore della collagenasi |
| US6583109B1 (en) | 1997-06-24 | 2003-06-24 | Robert C. Gallo | Therapeutic polypeptides from β-hCG and derivatives |
| WO1999015191A2 (en) | 1997-09-19 | 1999-04-01 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Cytokines having neurotrophic activity |
| US6165783A (en) | 1997-10-24 | 2000-12-26 | Neuro Spheres Holdings Ltd. | Erythropoietin-mediated neurogenesis |
| EP1032388A4 (en) | 1997-10-31 | 2002-10-02 | Smithkline Beecham Corp | NEW METAL COMPLEXES |
| TW445295B (en) | 1997-12-31 | 2001-07-11 | Shiu Li Wei | Expression vector pcDNA3.1-HC for human erythropoietin, BHK-21 host cell line transformed therewith, and production of human erythropoietin using the transformed cell |
| US6812027B2 (en) | 1998-03-25 | 2004-11-02 | Cornell Research Foundation, Inc. | Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain |
| US6242563B1 (en) | 1998-07-20 | 2001-06-05 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Peptide analogues |
| SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| DE19857609A1 (de) | 1998-12-14 | 2000-06-15 | Hannelore Ehrenreich | Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen |
| FR2794473B1 (fr) | 1999-06-03 | 2003-09-26 | Centre Nat Rech Scient | Procede de multiplication de cellules souches |
| US6618698B1 (en) | 1999-08-12 | 2003-09-09 | Quickturn Design Systems, Inc. | Clustered processors in an emulation engine |
| US6395546B1 (en) | 2000-02-01 | 2002-05-28 | Neurogeneration, Inc. | Generation of dopaminergic neurons from human nervous system stem cells |
| KR100358754B1 (ko) * | 2000-02-14 | 2002-11-07 | 대한민국 | 인간의 조혈촉진제 생산을 위한 형질전환 돼지를 생산하는방법 및 그 형질전환 돼지 |
| US7259146B2 (en) | 2000-05-26 | 2007-08-21 | Ortho-Mcneil Pharmaceutical, Inc. | Neuroprotective peptides |
| AU7107301A (en) | 2000-07-18 | 2002-01-30 | Nichimo Co. Ltd. | Stem cell reinforcing material |
| ES2315350T3 (es) | 2001-01-12 | 2009-04-01 | Waratah Pharmaceuticals Inc. | Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg. |
| US6740163B1 (en) | 2001-06-15 | 2004-05-25 | Seagate Technology Llc | Photoresist recirculation and viscosity control for dip coating applications |
| WO2002102988A2 (en) | 2001-06-18 | 2002-12-27 | Psychiatric Genomics, Inc. | Method for neural stem cell differentiation using 5ht-1a agonists |
| EP1415463A4 (en) | 2001-07-19 | 2005-10-12 | Thomson Licensing | Robust reception of digital broadcast transmission |
| CA2364095C (en) | 2001-07-20 | 2011-07-12 | Neurostasis, Inc | Production of radial glial cells |
| EP1423509A2 (en) * | 2001-08-30 | 2004-06-02 | Stem Cell Therapeutics Inc. | Differentiation of neural stem cells and therapeutic use thereof |
| EP1430114B1 (en) * | 2001-09-14 | 2012-01-18 | Stem Cell Therapeutics Inc. | Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| AR036402A1 (es) | 2001-09-18 | 2004-09-08 | Stem Cell Therapeutics Inc | Efecto de la hormona de crecimiento y de igf-1 sobre celulas madre neuronales. |
| ITPR20010072A1 (it) | 2001-10-26 | 2003-04-26 | Firaco Srl | Apparato e procedimento di sicurezza per veicoli di trasporto, in particolare aeromobili. |
| WO2003092716A2 (en) | 2002-05-03 | 2003-11-13 | Neuronova Ab | Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| WO2004011497A1 (en) | 2002-07-31 | 2004-02-05 | Stem Cell Therapeutics Inc. | Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
| WO2004011021A1 (en) | 2002-07-31 | 2004-02-05 | Stem Cell Therapeutics Inc. | Method of enhancing and/or inducing neuronal migration using erythropoietin |
| US20050009847A1 (en) | 2002-11-20 | 2005-01-13 | Goran Bertilsson | Compounds and methods for increasing neurogenesis |
| JP2006521405A (ja) | 2003-03-27 | 2006-09-21 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 発作回復におけるエリトロポイエチンの使用 |
| US20070111932A1 (en) | 2003-07-31 | 2007-05-17 | Stem Cell Therapeutics Inc. | Method of enhancing and/or inducing neuronal migration using erythropoietin |
| ES2392282T3 (es) | 2004-02-13 | 2012-12-07 | Stem Cell Therapeutics Corp. | Uso de la hormona luteinizante (LH) y de la gonadotropina coriónica (hCG) para la proliferación de células precursoras neurales y la neurogénesis |
| AU2005291810B2 (en) * | 2004-10-07 | 2011-12-08 | Stem Cell Therapeutics Corp. | Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
| KR20080074108A (ko) | 2005-09-27 | 2008-08-12 | 스템 셀 테라퓨틱스 코포레이션 | 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식 |
| WO2007106986A1 (en) | 2006-03-17 | 2007-09-27 | Stem Cell Therapeutics Corp. | Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
| WO2008077027A2 (en) | 2006-12-18 | 2008-06-26 | Case Western Reserve University | Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders |
| WO2008077085A1 (en) | 2006-12-19 | 2008-06-26 | Case Western Reserve University | Brain-derived gonadotropins and cognition |
| US20080286234A1 (en) | 2007-05-15 | 2008-11-20 | Eyink Daniel A | Method for treating demyelinating diseases |
-
2007
- 2007-03-16 WO PCT/CA2007/000426 patent/WO2007106986A1/en not_active Ceased
- 2007-03-16 US US11/687,302 patent/US8143220B2/en not_active Expired - Fee Related
- 2007-03-16 US US12/293,408 patent/US8333974B2/en not_active Expired - Fee Related
- 2007-03-16 JP JP2008558609A patent/JP2009530234A/ja active Pending
- 2007-03-16 AU AU2007229300A patent/AU2007229300B2/en not_active Expired - Fee Related
- 2007-03-16 KR KR1020087025237A patent/KR20080103108A/ko not_active Ceased
- 2007-03-16 CA CA002644116A patent/CA2644116A1/en not_active Abandoned
- 2007-03-16 EP EP07710755A patent/EP2004212A4/en not_active Withdrawn
- 2007-03-16 KR KR1020087025235A patent/KR20080106976A/ko not_active Withdrawn
- 2007-03-16 AU AU2007229301A patent/AU2007229301B2/en not_active Expired - Fee Related
- 2007-03-16 CA CA002643502A patent/CA2643502A1/en not_active Abandoned
- 2007-03-16 WO PCT/CA2007/000427 patent/WO2007106987A1/en not_active Ceased
- 2007-03-16 JP JP2008558610A patent/JP2009530235A/ja active Pending
- 2007-03-16 EP EP07710754A patent/EP2004211A4/en not_active Withdrawn
-
2008
- 2008-09-02 IL IL193856A patent/IL193856A0/en unknown
- 2008-09-02 IL IL193857A patent/IL193857A0/en unknown
-
2010
- 2010-03-12 JP JP2010056766A patent/JP2010138203A/ja active Pending
- 2010-03-12 JP JP2010056764A patent/JP2010138202A/ja active Pending
-
2012
- 2012-02-21 US US13/401,323 patent/US20120270779A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120270779A1 (en) | 2012-10-25 |
| EP2004212A1 (en) | 2008-12-24 |
| AU2007229300A1 (en) | 2007-09-27 |
| EP2004211A1 (en) | 2008-12-24 |
| CA2643502A1 (en) | 2007-09-27 |
| JP2010138202A (ja) | 2010-06-24 |
| EP2004212A4 (en) | 2010-07-14 |
| KR20080103108A (ko) | 2008-11-26 |
| US8143220B2 (en) | 2012-03-27 |
| WO2007106986A8 (en) | 2008-03-06 |
| IL193856A0 (en) | 2011-08-01 |
| AU2007229301A1 (en) | 2007-09-27 |
| IL193857A0 (en) | 2011-08-01 |
| EP2004211A4 (en) | 2010-07-07 |
| AU2007229301B2 (en) | 2013-08-01 |
| WO2007106987A1 (en) | 2007-09-27 |
| US20090081205A1 (en) | 2009-03-26 |
| JP2009530234A (ja) | 2009-08-27 |
| JP2010138203A (ja) | 2010-06-24 |
| AU2007229300B2 (en) | 2013-08-01 |
| WO2007106986A1 (en) | 2007-09-27 |
| JP2009530235A (ja) | 2009-08-27 |
| US8333974B2 (en) | 2012-12-18 |
| KR20080106976A (ko) | 2008-12-09 |
| US20080039389A1 (en) | 2008-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007229301B2 (en) | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents | |
| KR20080074108A (ko) | 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식 | |
| AU2002325712B2 (en) | Differentiation of neural stem cells and therapeutic use theeof | |
| US20120071404A1 (en) | Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds | |
| AU2002325712A1 (en) | Differentiation of neural stem cells and therapeutic use theeof | |
| JP4990634B2 (ja) | 神経幹細胞の増殖および神経発生のための黄体化ホルモン(LH)、および絨毛性ゴナドトロピン(hCG)の使用 | |
| CN101405021A (zh) | 神经干细胞增殖试剂和神经干细胞分化试剂的连续给药方案 | |
| TW200810774A (en) | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents | |
| US20060105958A1 (en) | Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis | |
| AU2013201345A1 (en) | Oligodendrocyte precursor cell proliferation regulated by prolactin | |
| HK1156232A (en) | Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds | |
| JP2007530578A (ja) | エリスロポエチンのための組合せ投薬養生方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20140402 |